Similac Cronobacter Investigation Handed Off to Special FDA Unit
An FDA Incident Management Group now leads the investigation into Cronobacter illnesses among infants who consumed Similac infant formula, the agency has announced today. Up until now, the active investigation was helmed by the U.S. Food and Drug Administration’s (FDA’s) CORE Response Team, which has been tasked with investigating food poisoning outbreaks since its creation […]